POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval

By sjmartinez • May 28, 2023

Bikhchandani M, Amersi F, Hendifar A, Gangi A, Osipov A, Zaghiyan K, Atkins K, Cho M, Aguirre F, Hazelett D, Alvarez R, Zhou L, Hitchins M, Gong J. POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval. Genes (Basel). 2023 May 8;14(5):1054. doi: 10.3390/genes14051054. PMID: 37239414; PMCID: PMC10218075.

Tags: Cedars Sinai DoM, Checkpoint Inhibitor, Colon cancer, Hematology/Oncology, high tumor mutation burden, immunotherapy, MSS, POLE, Publications

Stress Trajectory and Hypertension 2 to 7 Years After Delivery: A nuMoM2b-HHS Study

Nuckols VR, Barone Gibbs B, Brewer BC, Gaffey AE, Greaney JL, Patterson F, Greenland P, Saade GR, Grobman WA, Yee LM, Bairey Merz CN, Chung[...]

Dietary Intake of Macronutrients and Micronutrients in Women with Functional Hypothalamic Amenorrhea

Uddenberg ER, Safwan N, Castaneda R, Saadedine M, Maughan J, Hurtado Andrade MD, Faubion SS, Pisarska MD, Berga SL, Manson JE, Merz CNB, Shufelt CL.[...]

Dynamic transcriptomic remodeling in grafted human neural progenitor cells uncovers mechanisms for vision preservation in a rat model of retinitis pigmentosa

Shahin S, Bell S, Lu B, Banerjee S, Swarup V, Xu H, Chetsawang J, Ramirez S, Alfaro JS, Laperle A, Svendsen S, Svendsen CN, Wang[...]